image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Synergy Health

June 2011

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SYR
  • Price:
  • 873p
In order to gain its first foothold in the USA Synergy has announced the acquisition of BeamOne, the largest provider of outsourced, e-beam medical device sterilisation services for an initial US$35m cash. A deferred payment of up to a further US$20m will also be made  depending on performance. BeamOne, which has FDA approved sites in California, Colorado, Pennsylvania as well as one in Costa Rica, generated revenues of US$14.3m and pretax profit of US$2.7m in the year to 31 December. The deal will give Synergy access to a US$600m market and provides a platform to develop a world class central sterilisation business for US hospitals and healthcare providers. Alongside China it represents a second major new leg to growth. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X